Apellis Pharmaceuticals Set to Attend Upcoming Investor Conferences

Written by Emily J. Thompson, Senior Investment Analyst

Source: Globenewswire

Updated: Aug 26 2025

0mins

Source: Globenewswire

Upcoming Investor Conferences: Apellis Pharmaceuticals will participate in three investor conferences, including the Wells Fargo Healthcare Conference on September 3, Cantor Global Healthcare Conference on September 4, and Baird Global Healthcare Conference on September 9, 2025.
Webcast Availability: Live webcasts of the conferences will be available on the company's website, with replays accessible for approximately 30 days post-event.
Company Overview: Apellis Pharmaceuticals is a biopharmaceutical company focused on complement science, developing therapies for serious diseases, including treatments for geographic atrophy and rare kidney diseases.
Future Potential: The company believes there is significant potential in targeting C3 to address various serious diseases beyond their current approved therapies.

Get Free Real-Time Notifications for Any Stock

Monitor tickers like undefined with instant alerts to capture every critical market movement.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.